Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Department of Hepatology, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris, INSERM U773, University of Paris-VII, Clichy, France.
Clin Gastroenterol Hepatol. 2015 Jan;13(1):27-36. doi: 10.1016/j.cgh.2014.04.039. Epub 2014 Jun 5.
With widespread screening and increasingly effective treatments for patients with viral hepatitis as well as the increasing prevalence of nonalcoholic fatty liver disease, the population presenting to the care of gastroenterologists and hepatologists is certain to increase. Assessment of advanced liver disease is traditionally invasive and expensive. Vibration-controlled transient elastography, commonly delivered by the FibroScan device, is an option recently approved by the Food and Drug Administration for the noninvasive assessment of liver disease at the point of care. Herein, we review the promise and pitfalls of vibration-controlled transient elastography with the aim of providing clinicians with a framework to interpret its results and apply this technology to the changing needs of our patients.
随着病毒性肝炎患者的广泛筛查和日益有效的治疗方法，以及非酒精性脂肪性肝病的患病率不断上升，到胃肠病学家和肝病学家处就诊的患者人数肯定会增加。晚期肝病的评估传统上是有创性的和昂贵的。振动控制瞬时弹性成像，通常由 FibroScan 设备提供，是食品和药物管理局最近批准的一种选择，用于在护理点进行非侵入性的肝病评估。在此，我们回顾了振动控制瞬时弹性成像的前景和陷阱，旨在为临床医生提供一个解释其结果的框架，并将这项技术应用于我们患者不断变化的需求。
